News archive

247 stories in this category

Nature Aging · 3 Sept 2026 · Supplements / medicine

GLP-1 receptor agonism extends median lifespan in mice

Commentary. A Nature Aging research highlight on mouse work in which GLP-1 receptor agonism was associated with a longer median lifespan. This is laboratory animal research, not a human trial and not a reason to start, stop, or change any medicine. VitaLonga does not prescribe GLP-1 drugs or sell them as longevity treatments. Educational supplement parallel (not a replacement): When headlines discuss GLP-1 medicines and aging, people often research food-first fiber or bitter-botanical “pathway support” formulas. Those are not semaglutide, not compounded GLP-1, and not a substitute for a prescribed GLP-1 drug. Mouse or marketing claims are hype until human outcome data exist. Weakly evidenced. Store: /store/glp1-pathway-support. Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline.

Read at Nature Aging →Our summary♡ Save

• Metabolic / glucose
• Medicine
• Aging
• Longevity

• commentary
• longevity
• aging
• research
• study
• glp1

News-Medical · 2 Sept 2026 · Supplements / medicine

Menopause may start changing the gut years before periods stop

Study (observational). Shieh, Karlamangla and colleagues, using 964 women in the SWAN Bone Cohort with a known final menstrual period (mean age about 49 at first visit), report in the Journal of Clinical Investigation that circulating markers of gut-barrier strain (FABP2 and sCD14) rose across about nine years around menopause. FABP2 began climbing about 2.5 years before the final period and slowed about 6.5 years after; sCD14 lagged by about six months. This is indirect blood-marker work, not a leaky-gut diagnosis or a probiotic trial. Educational menopause-aging notes, not medical advice.

Read at News-Medical →Our summary♡ Save

• Women
• 40–59
• 60+
• Supplements
• Aging

• study
• women
• gut
• aging

News-Medical · 2 Sept 2026 · Supplements / medicine

Healthy ageing shaped by more varied biology than previously thought

Study (longitudinal). King’s College London researchers (Julia El-Sayed Moustafa, Kerrin Small and colleagues) report in Science the most comprehensive molecular aging map of its kind: 335 TwinsUK adults followed eight years with repeated blood RNA (~16,000 genes) and hundreds of metabolites. Two healthy people of the same age could show opposite molecular change. Trajectories differed for a cardiac-aging gene (CXCL9) and for TP53 in some people; PFAS “forever chemical” blood levels correlated with shifting profiles. Innate and adaptive immune cells did not age the same way. This is a roadmap paper, not a trial of a longevity supplement and not a diagnosis. Educational biology notes.

Read at News-Medical →Our summary♡ Save

• Cardiovascular / lipids
• Supplements
• Aging
• Longevity

• study
• aging
• research
• longevity

Medical Xpress · 2 Sept 2026 · Supplements / medicine

Healthier fats linked to longer survival after prostate cancer diagnosis

Study (observational). Using the Health Professionals Follow-Up Study, Harvard Chan and McGill researchers followed 4,884 men with nonmetastatic prostate cancer for a median 12.8 years (JAMA Network Open). Highest versus lowest saturated-fat intake associated with a 24% higher all-cause death rate (10-year risk 26.4% vs 23.4%), driven mainly by cardiovascular disease and other cancers, not prostate cancer itself. Modeled replacement of about 10% of calories from animal fat with plant fat associated with 16% lower all-cause mortality; replacing 5% of calories from saturated fat with monounsaturated fat associated with 20% lower. Association is not causation. Not a cancer treatment and not a supplement protocol. Simple food swaps (olive oil, nuts, seeds, avocado) are educational.

Read at Medical Xpress →Our summary♡ Save

• Men
• Cardiovascular / lipids
• Cancer
• Nutrition
• Supplements
• Aging
• Longevity

• study
• nutrition
• aging

EurekAlert · 2 Sept 2026 · Supplements / medicine

Boosting indoor light could help support healthy ageing in older adults in urban areas

Study. In the ENLIGHTENme trial (Journal of Pineal Research), University of Surrey researchers led by Débora Constantino and Daan van der Veen recruited 202 community-dwelling adults aged 63–92 in Tartu, Bologna, and Amsterdam. After a two-week wearable baseline, 98 were randomized to three months of a full-spectrum lamp in the most-used room (on within an hour of waking; off four hours before usual sleep) versus 93 controls. Earlier self-administered daytime light tracked with higher activity and less rest–activity fragmentation. This is real-world light hygiene, not a drug and not a sleep-disorder diagnosis. Educational, non-pharmacological notes; not medical advice.

Read at EurekAlert →Our summary♡ Save

• 60+
• Medicine
• Aging

• study
• aging
• research
• sleep

EurekAlert · 2 Sept 2026 · Supplements / medicine

Food keeps time, too — and your liver is listening for the dinner bell

Study (mice). Texas A&M biologists led by Jerome Menet report in Science Advances that meal timing drives rhythmic liver gene activity through the nutrient sensor mTOR, in partnership with—but not identical to—the organ’s circadian clock. Blocking mTOR cut rhythmic gene expression by about 50%. The same nutrient signal had different effects depending on time of day. The authors link the finding to shift work, jet lag, late-night eating, and time-restricted eating. This is laboratory animal work, not a human fasting trial and not a reason to treat metabolic disease with a supplement or a clock pill. Meal timing is educational; concentrated “chrono” products are weakly evidenced for this claim.

Read at EurekAlert →Our summary♡ Save

• Metabolic / glucose
• Nutrition
• Supplements

• study
• nutrition
• research

Nature · 2 Sept 2026 · Supplements / medicine

Late-life semaglutide treatment slows ageing and extends lifespan in female mice

Study (mice). Feng, Barthez, Chen and colleagues treated 20-month-old female C57BL/6 mice with the GLP-1 receptor agonist semaglutide. Median lifespan was 834 days versus 742 in controls (about 12% longer). Three months of treatment improved function and dampened aging hallmarks; treated mice ate about 24% fewer calories. A calorie-matched comparison suggested extra gains in exploratory drive, spatial memory, and glucose control beyond restriction alone. This is laboratory animal work in one sex and strain, not a human longevity trial. Semaglutide remains a prescription medicine for approved uses. Off-label aging use is clinician-only. This is not medical advice and not a reason to start, stop, or replace any drug. Educational supplement parallel (not a replacement): When headlines discuss GLP-1 medicines and aging, people often research food-first fiber or bitter-botanical “pathway support” formulas. Those are not semaglutide, not compounded GLP-1, and not a substitute for a prescribed GLP-1 drug. Mouse or marketing claims are hype until human outcome data exist. Weakly evidenced. Store: /store/glp1-pathway-support. Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline.

Read at Nature →Our summary♡ Save

• Metabolic / glucose
• Cognitive / dementia research
• Nutrition
• Supplements
• Medicine
• Aging
• Longevity

• study
• longevity
• aging
• research
• glp1
• off-label-context
• cognition
• nutrition

ScienceDaily · 2 Sept 2026 · Supplements / medicine

Each extra hour of prolonged sitting linked to 9% higher cancer death risk

Study (observational). University of Glasgow researchers writing in PLOS Medicine followed 91,292 UK Biobank adults who wore activity monitors for 7 days, then tracked them a median 12.38 years. Each extra hour of sitting lasting at least 30 minutes tracked with 9% higher cancer mortality (HR 1.09). Replacing one hour of prolonged sitting with light activity associated with 12% lower cancer death risk (HR 0.88). Interrupted sitting showed the opposite pattern. This is association, not proof that sitting causes cancer. UK Biobank volunteers tend to be healthier than average. Breaking up long sits is a movement habit, not a disease treatment.

Read at ScienceDaily →Our summary♡ Save

• Cancer
• Exercise
• Medicine
• Aging
• Longevity

• study
• fitness
• aging

ScienceDaily · 1 Sept 2026 · Supplements / medicine

Obesity leaves a lasting memory in immune cells

Study. A University of Birmingham–led team reports in EMBO Reports that helper T cells (CD4+ lymphocytes) can keep DNA-methylation marks linked to past obesity for an estimated 5–10 years after weight loss. The 10-year project sampled blood and fat from people after weight-loss injections, a genetic early-onset obesity condition, a 10-week exercise program, and joint-replacement surgery, plus high-fat-diet mice. Authors suggest autophagy and immune senescence pathways may stay altered, which could help explain leftover disease risk after weight returns toward normal. This is mechanistic human and mouse work, not a claim that any supplement erases “obesity memory.” Weight-management decisions belong with a clinician.

Read at ScienceDaily →Our summary♡ Save

• Metabolic / glucose
• Cognitive / dementia research
• Exercise
• Nutrition
• Supplements
• Medicine
• Aging

• study
• nutrition
• aging
• research
• cognition
• fitness

U.S. News & World Report · 1 Sept 2026 · Supplements / medicine

Health experts rank daily habits ahead of biohacks for healthy aging

Commentary (expert survey). U.S. News’s 2026 Healthy Aging Survey of 63 clinicians, dietitians, and researchers (July–August 2026) ranked consistent physical activity (89%) and a nutrient-dense diet (89%) as the top factors for healthy aging, with restorative sleep third (30%). Fifty-nine percent named social isolation the most underappreciated accelerator of biological aging. Seventy-six percent warned that accelerated muscle loss is a serious threat for people using GLP-1 medicines. This is expert opinion, not a clinical trial and not a product protocol. Strength, aerobic, balance, and mobility work plus food-first nutrition remain the basics; supplements are not a substitute for those habits. Educational supplement parallel (not a replacement): When headlines discuss GLP-1 medicines and aging, people often research food-first fiber or bitter-botanical “pathway support” formulas. Those are not semaglutide, not compounded GLP-1, and not a substitute for a prescribed GLP-1 drug. Mouse or marketing claims are hype until human outcome data exist. Weakly evidenced. Store: /store/glp1-pathway-support. Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline.

Read at U.S. News & World Report →Our summary♡ Save

• Metabolic / glucose
• Exercise
• Nutrition
• Supplements
• Medicine
• Aging

• commentary
• fitness
• nutrition
• aging
• glp1
• off-label-context
• sleep
• study

News-Medical · 31 Aug 2026 · Supplements / medicine

Aerobic exercise boosts executive function in postmenopausal women

Study (randomized). Rutgers researchers led by Sharon Sanz Simon report in the Journal of Alzheimer’s Disease that 93 healthy women ages 20–67 (43% postmenopausal), starting below-average fitness and not regular exercisers, were assigned to six months of aerobic training or stretching-and-toning. Post-menopausal women in the aerobic arm improved executive function (task-switching speed and error management) more than the stretch group and more than pre-menopausal women on the same aerobic program. Gains appeared by three months and continued to six. Memory and processing speed did not show the same change. About 8 in 10 completed three months and 7 in 10 the full six. This is educational movement, not a dementia treatment or a supplement protocol.

Read at News-Medical →Our summary♡ Save

• Women
• 40–59
• 60+
• Cognitive / dementia research
• Exercise
• Supplements

• study
• fitness
• cognition

The Lancet Healthy Longevity · 28 Aug 2026 · Supplements / medicine

Reframing sarcopenia as a disease of the ageing motor system

Commentary (personal view). A Lancet Healthy Longevity essay argues that age-related strength loss is not only shrinking muscle tissue. Trials of anabolic drugs or protein that raised lean mass often yielded modest function gains, while resistance training can improve strength and performance even when mass barely changes—because it also loads neural circuits, coordination, and blood flow. The piece favors progressive resistance work, balance, and motor-learning tasks over mass-only targets. Educational context, not a clinic protocol and not a claim that any supplement treats sarcopenia.

Read at The Lancet Healthy Longevity →Our summary♡ Save

• Exercise
• Supplements
• Medicine
• Aging
• Longevity

• commentary
• fitness
• aging
• muscle
• longevity
• study

VitaLonga is an educational longevity resource, not a pharmacy, clinic, or doctor. Content is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease (DSHEA). Supplements can interact with medications and are not appropriate in every pregnancy or health condition. Consult a licensed clinician, especially if you take medications, are pregnant or nursing, or have a diagnosed condition.